Sunscreen Innovation Act: Section 586C(c) Advisory Committee Process October 2016
- Docket Number:
- Issued by:
Guidance Issuing OfficeCenter for Drug Evaluation and Research
This guidance addresses the process by which the Food and Drug Administration (FDA or Agency) intends to carry out section 586C(c) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360fff-3(c)), as amended by Public Law 113-195 (also referred to as the Sunscreen Innovation Act (SIA)).
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2015-D-3990.